Log in to save to my catalogue

Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preven...

Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preven...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1951417190

Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation

About this item

Full title

Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation

Publisher

United States: Oxford University Press

Journal title

Clinical infectious diseases, 2017-12, Vol.65 (12), p.1977-1983

Language

English

Formats

Publication information

Publisher

United States: Oxford University Press

More information

Scope and Contents

Contents

Infants aged <1 year are at highest risk for pertussis-related morbidity and mortality. In 2012, Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis) vaccine was recommended for women during each pregnancy to protect infants in the first months of life; data on effectiveness of this strategy are currently limited.
We conduct...

Alternative Titles

Full title

Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1951417190

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1951417190

Other Identifiers

ISSN

1058-4838

E-ISSN

1537-6591

DOI

10.1093/cid/cix724

How to access this item